ClarificationAug 7, 2026, 03:41 PM
OSR Health Clarifies Nasdaq Stance on CVR Program
AI Summary
OSR Health, Inc. issued a press release clarifying its previous communication dated July 31, 2026, concerning The Nasdaq Stock Market LLC and the Company's Shareholder Loyalty Contingent Value Rights (CVR) program. The company clarified that Nasdaq has not approved or endorsed the CVR program, and its earlier communication was a preliminary, verbal indication limited to a technical question about stock price adjustment. The clarification does not alter the previously announced August 14, 2026 record date for the CVR program.
Key Highlights
- OSR Health clarified its July 31, 2026 press release regarding Nasdaq communication.
- Nasdaq has not approved or endorsed the Shareholder Loyalty CVR Program.
- Nasdaq's prior communication was a preliminary, verbal indication on a technical question.
- The technical question concerned mechanical adjustment to common stock price.
- The August 14, 2026 record date for the CVR program remains unchanged.
- Program details and eligibility are available at www.osr-health.com/loyaltyprogram.
Price Impact
More from OSRH